SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001213900-24-001370
Filing Date
2024-01-05
Accepted
2024-01-05 10:49:07
Documents
62
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT f10k2023_actavialife.htm   iXBRL 10-K 1046685
2 CERTIFICATION f10k2023ex31-1_actavialife.htm EX-31.1 11239
3 CERTIFICATION f10k2023ex31-2_actavialife.htm EX-31.2 11354
4 CERTIFICATION f10k2023ex32-1_actavialife.htm EX-32.1 3752
5 CERTIFICATION f10k2023ex32-2_actavialife.htm EX-32.2 3772
  Complete submission text file 0001213900-24-001370.txt   4667356

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE rasp-20230930.xsd EX-101.SCH 51335
7 XBRL CALCULATION FILE rasp-20230930_cal.xml EX-101.CAL 28583
8 XBRL DEFINITION FILE rasp-20230930_def.xml EX-101.DEF 205444
9 XBRL LABEL FILE rasp-20230930_lab.xml EX-101.LAB 450992
10 XBRL PRESENTATION FILE rasp-20230930_pre.xml EX-101.PRE 221174
56 EXTRACTED XBRL INSTANCE DOCUMENT f10k2023_actavialife_htm.xml XML 438838
Mailing Address 5 PENN PLAZA, 19TH FLOOR, #1954 NEW YORK NY 10001
Business Address 5 PENN PLAZA, 19TH FLOOR, #1954 NEW YORK NY 10001 646-396-4087
ACTAVIA LIFE SCIENCES, INC. (Filer) CIK: 0001582249 (see all company filings)

IRS No.: 392080103 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-K | Act: 34 | File No.: 333-191083 | Film No.: 24514873
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)